Terry C. Major - Concepedia

Author

Terry C. Major

University of Michigan ORCID

Also Known As

T C Major, T Major, T. C. Major, T. Major, T.C. Major, Terry C Major, Terry C. Major, Terry Major

Publications

3.9K

Citations

H-Index

101

Concepts

All Affiliations

University of Michigan Pfizer (United States)Warde Medical Laboratory University of Georgia

About

Terry C. Major is an author at University of Michigan specializing in medicine, biomedical engineering, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	29	1.6K
2	Engineering	17	19	1.1K
3	Natural Sciences	5	5	321
4	Health Sciences	4	4	356
5	Anesthesia	1	1	57

Terry C. Major

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Subclasses of angiotensin II binding sites and their functional significance. David T. Dudley, Robert L. Panek, Terry C. Major, Molecular Pharmacology	1990	378
Measurement of Tear Glucose Levels with Amperometric Glucose Biosensor/Capillary Tube Configuration Qinyi Yan, Bo Peng, Gang Su, Analytical Chemistry EngineeringBioelectrochemistryBiochemical SensorsGlucose SensorBiomedical Engineering	2011	180
Circulating Succinate is Elevated in Rodent Models of Hypertension and Metabolic Disease<subtitle /> Nalini Sadagopan, Wenlin Li, Steven L. Roberds, American Journal of Hypertension	2007	160
Long-term nitric oxide release and elevated temperature stability with S-nitroso-N-acetylpenicillamine (SNAP)-doped Elast-eon E2As polymer Elizabeth J. Brisbois, Hitesh Handa, Terry C. Major, Biomaterials Materials ScienceChemical EngineeringEngineeringElevated Temperature StabilityPolymer Science	2013	160
Structure−Activity Relationships for a Novel Series of Pyrido[2,3-<i>d</i>]pyrimidine Tyrosine Kinase Inhibitors James M. Hamby, Cleo J. C. Connolly, Mel C. Schroeder, Journal of Medicinal Chemistry PharmacotherapyCompound LibraryHeterocycle ChemistryChemical BiologyPharmaceutical Chemistry	1997	141
The attenuation of platelet and monocyte activation in a rabbit model of extracorporeal circulation by a nitric oxide releasing polymer Terry C. Major, David O. Brant, Melissa M. Reynolds, Biomaterials InflammationThrombosisThrombopoiesisMonocyte ActivationExtracorporeal Circulation	2009	133
2-Substituted Aminopyrido[2,3-<i>d</i>]pyrimidin-7(8<i>H</i>)-ones. Structure−Activity Relationships Against Selected Tyrosine Kinases and in Vitro and in Vivo Anticancer Activity S. KLUTCHKO, James M. Hamby, Diane H. Boschelli, Journal of Medicinal Chemistry	1998	130
Origin of Long-Term Storage Stability and Nitric Oxide Release Behavior of CarboSil Polymer Doped with <i>S</i>-Nitroso-<i>N</i>-acetyl-<scp>d</scp>-penicillamine Yaqi Wo, Zi Li, Elizabeth J. Brisbois, ACS Applied Materials & Interfaces	2015	116
The hemocompatibility of a nitric oxide generating polymer that catalyzes S-nitrosothiol decomposition in an extracorporeal circulation model Terry C. Major, David O. Brant, Charles P. Burney, Biomaterials Assisted CirculationChemical EngineeringS-nitrosothiol DecompositionEngineeringNitric Oxide	2011	114
The ACAT Inhibitor Avasimibe Reduces Macrophages and Matrix Metalloproteinase Expression in Atherosclerotic Lesions of Hypercholesterolemic Rabbits Thomas Bocan, Brian R. Krause, Wendy S. Rosebury, Arteriosclerosis Thrombosis and Vascular Biology Vascular DiseaseMatrix Metalloproteinase ExpressionImmunologyPathologyHyperlipidemia	2000	113

Page 1